Director/PDMR Shareholding

Medica Group PLC
05 July 2023
 

Medica Group PLC

 

Director / PDMR Shareholding

 

Medica Group PLC (the "Company") announces that on 4 July 2023, the PDMRs listed below had options that vested and were exercised due to the approval of Scheme of Arrangement via Court Sanction hearing. The exercised options were ordinary shares of 0.2p each in the Company under the Company's Performance Share Plan 2017, Deferred Bonus Plan 2017 and Save As You Earn Scheme:

 

Name of PDMR

Number of shares subject to options

Stuart Quin


744,671

Richard Jones


545,399

Kevin Terrins


284,292

Sarah Burns


226,457

Marc O'Brien

Caroline Byrne

Rob Lavis

Fiona Carr


288,130

139,141

193,342

43,780

Kim Scanlan


32,905

 

The notifications set out below are provided in accordance with the requirements of the UK Market Abuse Regulation, and set out more details of the transactions.

 

1.

Details of PDMR

(a)

Name

1.           Stuart Quin

2.           Richard Jones

3.           Kevin Terrins

4.           Sarah Burns

5.           Marc O'Brien

6.           Caroline Byrne

7.           Rob Lavis

8.           Fiona Carr

9.           Kim Scanlan

 

2.

Reason for notification

(b)

Position / status

1.           Chief Executive Officer

2.           Chief Financial Officer

3.           Group Director of Corporate Development

4.           Managing Director, UK

5.           Chief Information Officer

6.           Managing Director, Ireland

7.           Group Medical Director

8.           Group Head of Human Resources

9.           Managing Director, US

 


Initial notification / amendment

Initial notification in each case

3.

Details of the Issuer

(a)

Name

Medica Group PLC

(b)

LEI

213800B8XE5FUSZF5Z16

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) have been conducted

(a)

Description of the financial instrument

Ordinary shares of 0.2p each in the capital of the Company ("Shares")

(b)

Nature of the transaction

Vesting and exercise of options over Shares pursuant to the Company's Performance Share Plan 2017

(c)

Price(s) and volume

£Nil Option Price in each case

1.  597,579     

2.  454,832        

3.  217,565        

4.  175,869  

5.  212,516     

6.  85,323       

7.  154,811      

8.  37,141        

9.  32,905        

 

(d)

Aggregated information

N/A

(e)

Date of the transaction

4 July 2023

(f)

Place of the transaction

Outside a trading venue

 

1.

Details of PDMR

(a)

Name

1.           Stuart Quin

2.           Richard Jones

3.           Kevin Terrins

4.           Sarah Burns

5.           Marc O'Brien

6.           Caroline Byrne

7.           Rob Lavis

8.           Fiona Carr

9.           Kim Scanlan

 

2.

Reason for notification

(b)

Position / status

1.           Chief Executive Officer

2.           Chief Financial Officer

3.           Group Director of Corporate Development

4.           Managing Director, UK

5.           Chief Information Officer

6.           Managing Director, Ireland

7.           Group Medical Director

8.           Group Head of Human Resources

9.           Managing Director, US

 


Initial notification / amendment

Initial notification in each case

3.

Details of the Issuer

(a)

Name

Medica Group PLC

(b)

LEI

213800B8XE5FUSZF5Z16

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) have been conducted

(a)

Description of the financial instrument

Ordinary shares of 0.2p each in the capital of the Company ("Shares")

(b)

Nature of the transaction

Vesting and exercise of options over Shares pursuant to the Deferred Bonus Plan 2017

(c)

Price(s) and volume

£Nil Option Price in each case

1. 129,092      

2. 82,006         

3. 48,727         

4. 42,027    

5. 57,614        

6. 53,818   

7. 35,107       

8. 5,725   

9.  -      

 

(d)

Aggregated information

N/A

(e)

Date of the transaction

4 July 2023

(f)

Place of the transaction

Outside a trading venue

 

1.

Details of PDMR

(a)

Name

1.           Stuart Quin

2.           Richard Jones

3.           Kevin Terrins

4.           Sarah Burns

5.           Marc O'Brien

6.           Caroline Byrne

7.           Rob Lavis

8.           Fiona Carr

9.           Kim Scanlan

 

2.

Reason for notification

(b)

Position / status

1.           Chief Executive Officer

2.           Chief Financial Officer

3.           Group Director of Corporate Development

4.           Managing Director, UK

5.           Chief Information Officer

6.           Managing Director, Ireland

7.           Group Medical Director

8.           Group Head of Human Resources

9.           Managing Director, US

 


Initial notification / amendment

Initial notification in each case

3.

Details of the Issuer

(a)

Name

Medica Group PLC

(b)

LEI

213800B8XE5FUSZF5Z16

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) have been conducted

(a)

Description of the financial instrument

Ordinary shares of 0.2p each in the capital of the Company ("Shares")

(b)

Nature of the transaction

Vesting and exercise of options over Shares pursuant to the Save As Your Earn Scheme 2020

(c)

Price(s) and volume

£1.00 Option Price in each case

1. 18,000        

2.  -        

3. 18,000        

4.  -   

5. 18,000      

6.  -       

7.  -       

8.  -        

9.  -        

 

(d)

Aggregated information

N/A

(e)

Date of the transaction

4 July 2023

(f)

Place of the transaction

Outside a trading venue

 

1.

Details of PDMR

(a)

Name

1.           Stuart Quin

2.           Richard Jones

3.           Kevin Terrins

4.           Sarah Burns

5.           Marc O'Brien

6.           Caroline Byrne

7.           Rob Lavis

8.           Fiona Carr

9.           Kim Scanlan

 

2.

Reason for notification

(b)

Position / status

1.           Chief Executive Officer

2.           Chief Financial Officer

3.           Group Director of Corporate Development

4.           Managing Director, UK

5.           Chief Information Officer

6.           Managing Director, Ireland

7.           Group Medical Director

8.           Group Head of Human Resources

9.           Managing Director, US

 


Initial notification / amendment

Initial notification in each case

3.

Details of the Issuer

(a)

Name

Medica Group PLC

(b)

LEI

213800B8XE5FUSZF5Z16

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) have been conducted

(a)

Description of the financial instrument

Ordinary shares of 0.2p each in the capital of the Company ("Shares")

(b)

Nature of the transaction

Vesting and exercise of options over Shares pursuant to the Save As Your Earn Scheme 2021

(c)

Price(s) and volume

£1.46 Option Price in each case

1.  -       

2.  8,561       

3.  -        

4.  8,561        

5.  -        

6.  -        

7.  3,424       

8.  -        

9.  -        

 

(d)

Aggregated information

N/A

(e)

Date of the transaction

4 July 2023

(f)

Place of the transaction

Outside a trading venue

 

1.

Details of PDMR

(a)

Name

1.           Stuart Quin

2.           Richard Jones

3.           Kevin Terrins

4.           Sarah Burns

5.           Marc O'Brien

6.           Caroline Byrne

7.           Rob Lavis

8.           Fiona Carr

9.           Kim Scanlan

 

2.

Reason for notification

(b)

Position / status

1.           Chief Executive Officer

2.           Chief Financial Officer

3.           Group Director of Corporate Development

4.           Managing Director, UK

5.           Chief Information Officer

6.           Managing Director, Ireland

7.           Group Medical Director

8.           Group Head of Human Resources

9.           Managing Director, US

 


Initial notification / amendment

Initial notification in each case

3.

Details of the Issuer

(a)

Name

Medica Group PLC

(b)

LEI

213800B8XE5FUSZF5Z16

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) have been conducted

(a)

Description of the financial instrument

Ordinary shares of 0.2p each in the capital of the Company ("Shares")

(b)

Nature of the transaction

Vesting and exercise of options over Shares pursuant to the Save As Your Earn Scheme 2022

(c)

Price(s) and volume

£1.422 Option Price in each case

1.  -       

2.  -        

3.  -        

4.  -        

5.  -        

6.  -        

7.  -        

8. 914         

9.  -        

 

(d)

Aggregated information

N/A

(e)

Date of the transaction

4 July 2023

(f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Medica Group (MGP)
UK 100
FTSE quotes by TradingView

Latest directors dealings

All directors dealings today